Consistent with these observations, NSCLC cell lines silenced by the shRNA-PKM2 revealed a similar decrease in cytoplasmic PKM2 and increased expression in nuclei of NSCLC cells (S3 Table). This evidence concerns the gene PKM and non-small cell lung carcinoma.